CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Faster, Cheaper Cell Therapy with At‑Line QC

  Automated at‑line immunophenotyping QC streamlines cell therapy manufacturing, cutting turnaround time and cost while aligning with conventional methods and enabling scalable, reliable workflows.

• Digitized Solutions To Increase Visibility And Streamline Communication Between A PSP And Manufacturer

  When email-based escalation management creates compliance and visibility gaps, a centralized digital solution helps manufacturer and PSP teams act faster and with greater accountability.

• The Complete Flow Cytometry Guide

  This guide covers the fundamentals of flow cytometry, aiming to help you better understand how it works, when it is most valuable, and how to conduct an experiment.

• CAR Expression Detection Using Fluorescent Labeled Proteins, Flow Cytometry

  Learn how site-specific fluorescent labeling addresses key challenges in flow cytometry-based evaluations by enhancing assay sensitivity, reducing variability, and ensuring reliable results.

• What FDA CRLs Reveal About CCIT

  FDA rejection letters show common CCIT gaps — low sensitivity and incomplete validation. Spotting these trends helps teams strengthen integrity testing and avoid approval delays.

• A Toolkit For Unraveling Protein Expression Patterns

  Learn about a method that utilizes monoclonal antibodies and flow cytometry to analyze the metabolic state of individual immune cells, advancing immune research and immunotherapy.

• Improve mAb Purification Process Efficiency With Mixed-Mode Resins

  Does your monoclonal antibody (mAb) purification process have three steps? Are you trying to improve purity, yield, and process economics?

• A Shift Towards Biofluorescent Particle Counters In Manufacturing

  Sterility in injectable drug manufacturing is vital for patient safety and efficiency. Discover how biofluorescent particle counters revolutionize contamination control, regulatory compliance, and operational excellence in modern pharma.

• Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine

  Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.

• A Comprehensive Solution For Adventitious Agent Testing

  Modern sequencing methods offer sensitive detection of adventitious and species‑specific viruses. Learn how targeted and non‑targeted NGS approaches improve confidence in cell bank characterization.